Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters

Therapeutic Methods and Therapies TCIM
Database
Language
Affiliation country
Publication year range
2.
Urol Int ; 64(4): 209-12, 2000.
Article in English | MEDLINE | ID: mdl-10895086

ABSTRACT

We developed a serum-free coculture model of benign prostatic hyperplasia (BPH) to clarify whether stromal cells stimulate growth of epithelial cells from BPH tissues. Epithelial and stromal cells from freshly isolated BPH tissue were cultured separately in defined serum-free WAJC 404/RPMI 1640 medium supplemented with insulin, transferrin, selenium, hydrocortisone, bovine serum albumin, epidermal growth factor, basic fibroblast growth factor and keratinocyte growth factor. (3)H-Tdr incorporation into epithelial cells and stromal cells was used as a measure of proliferation. When epithelial cells were cocultured with stromal cells, (3)H-Tdr incorporation into epithelial cells was increased in comparison to that in epithelial cells cultured alone. Dihydrotestosterone significantly increased this effect. It is likely that the in vitro coculture model reported here will be useful for isolating and understanding stromal cell-derived paracrine growth factor(s).


Subject(s)
Fibroblast Growth Factors , Growth Substances , Keratinocytes , Prostatic Hyperplasia/pathology , Cell Division , Cells, Cultured , Culture Media, Conditioned , Epithelial Cells/pathology , Fibroblast Growth Factor 10 , Fibroblast Growth Factor 7 , Humans , Male , Stromal Cells/pathology
3.
Endocrinol Jpn ; 26(5): 541-7, 1979 Oct.
Article in English | MEDLINE | ID: mdl-393503

ABSTRACT

We describe the natural recovery from the aggravated hypertension, hypokalemia and suppression of the renin-aldosterone axis after the glycyrrhizin discontinuation in two mild hypertensive women aged 71 and 68 years, who had been administered 273 to 546 mg glycyrrhizin daily for 1.5 and 6 months, respectively, for the treatment of liver disease. About one month after the glycyrrhizin discontinuation, acceleration of hypertension, hypokalemia and suppression of the renin-aldosterone system still continued in both patients. At this stage, sodium restriction resulted in the normalization of blood pressure with weight loss and the subsequent sodium repletion produced a rapid increase in blood pressure to hypertensive levels observed before sodium restriction, with weight gain. Plasma renin activity and plasma aldosterone were low and did not respond to sodium restriction. Inappropriately excessive amounts of potassium were also excreted in the presence of hypokalemia. About one and a half months later, the improvements of aggravated hypertension, hypokalemia and suppressed renin-aldosterone system gradually occurred in both patients. Sodium restriction performed about three months later in case 2 no longer produced the changes in blood pressure and body weight. Plasma renin activity and plasma aldosterone responded subnormally to sodium restriction. These results demonstrate that both patients had a prolongation of the syndrome resembling primary aldosteronism except the low plasma aldosterone level about one month after the glycyrrhizin discontinuation. The possible mechanisms by which this prolongation was caused are discussed.


Subject(s)
Glycyrrhetinic Acid/analogs & derivatives , Hyperaldosteronism/chemically induced , Aged , Aldosterone/blood , Blood Pressure , Diet, Sodium-Restricted , Female , Glycyrrhetinic Acid/adverse effects , Glycyrrhiza , Humans , Hyperaldosteronism/blood , Hyperaldosteronism/physiopathology , Hypertension/chemically induced , Hypokalemia/chemically induced , Liver Diseases/drug therapy , Plants, Medicinal , Renin/blood , Time Factors
SELECTION OF CITATIONS
SEARCH DETAIL